Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Valves

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Chambers of the Heart

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...

Development of the Heart

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Agitated Saline Contrast Echocardiography in the diagnosis of right to left shunts: Guidance and recommendations from the British Society of Echocardiography.

Echo research and practice·2026

Same author

Late Embolization of a Patent Foramen Ovale Occluder Successfully Retrieved Percutaneously.

JACC. Case reports·2026

Same author

Management Approach for Residual and Recurrent Mitral Regurgitation After Transcatheter Edge-to-Edge Repair.

JACC. Cardiovascular interventions·2026

Same author

Impact of Proportionality of Secondary Tricuspid Regurgitation on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair.

Circulation. Cardiovascular interventions·2026

Same author

Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry.

JACC. Cardiovascular interventions·2026

Same author

Incidence, Predictors and Outcomes of Bleeding Following Transcatheter Tricuspid Valve Repair: The TriValve Registry.

JACC. Cardiovascular interventions·2026

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Atrial and ventricular shunt closure.

Nicolas Majunke¹, Horst Sievert

¹CardioVascular Center Frankfurt, Seckbacher Landstrasse 65, 60389 Frankfurt, Germany.

The Journal of Invasive Cardiology

|March 5, 2008

Summary

This summary is machine-generated.

Transcatheter closure of atrial septal defects is a safe and cost-effective alternative to surgery. This review covers atrial septal defect and ventricular septal defect closure techniques using device closure.

More Related Videos

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Related Experiment Videos

Last Updated: Jul 7, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Area of Science:

Cardiology
Interventional Cardiology
Medical Devices

Background:

Transcatheter closure of atrial septal defects (ASDs) is an established procedure.
Device closure offers a safe, cost-effective alternative to surgical repair.
Ventricular septal defect (VSD) closure is considered more complex.

Purpose of the Study:

To review current literature on transcatheter closure of ASDs and VSDs.
To present single-center data on device closure for ASDs and VSDs.
To compare transcatheter closure with surgical methods.

Main Methods:

Review of existing studies on transcatheter septal defect closure.
Analysis of single-center data from 875 patients undergoing ASD and VSD device closure.
Comparison of safety, efficacy, and cost-effectiveness.

Main Results:

Transcatheter ASD closure is safe and effective, comparable to surgery.
Device closure for ASDs has become a standard practice.
VSD closure presents unique challenges but is feasible with specific devices.

Conclusions:

Transcatheter device closure is a viable and preferred option for many ASDs.
Further research and device development are needed for complex VSD closures.
This approach offers significant benefits over traditional surgical interventions.